Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

BACKGROUND: The purpose of this study was to evaluate serum HE4 as a biomarker to detect recurrent disease during follow-up of patients with endometrial adenocarcinoma (EAC). METHODS: We performed a retrospective analysis of 98 EAC patients treated at Innsbruck Medical University, between 1999 and 2...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Brennan, Donal J, Hackethal, Andreas, Mann, Kristy P, Mutz-Dehbalaie, Irene, Fiegl, Heidi, Marth, Christian, Obermair, Andreas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342867/
https://ncbi.nlm.nih.gov/pubmed/25655024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1028-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller